Oncocytoma is a rare benign tumor of salivary glands, accounting for less than 1% of all salivary gland neoplasms. It most commonly occurs in the parotid gland (80%+). Histologically, it is entirely composed of oncocytic cells (epithelial cells with abundant granular eosinophilic cytoplasm and abundant mitochondria). These oncocytic cells are similar to the double-layered oncocytic epithelium in Warthin tumor but without lymphoid stroma. Clinically presents as a slowly growing, painless, firm parotid mass. Peak incidence between 60-80 years, slightly more common in females. Bilateral or multifocal oncocytoma is rare but has been described. Malignant transformation (oncocytic carcinoma) is very rare. The most important imaging feature is Tc-99m pertechnetate uptake (hot nodule) — this finding shared with Warthin tumor distinguishes these two tumors from other parotid tumors. The difference of oncocytoma from Warthin tumor is the absence of cystic component and solid homogeneous structure.
Age Range
50-80
Peak Age
65
Gender
Equal
Prevalence
Rare
The imaging findings of oncocytoma are based on the unique mitochondrial structure of oncocytic cells. Oncocytic cells contain 10-100 times more mitochondria than normal epithelial cells — this dense mitochondrial content determines the metabolic profile of the cells. Functional expression of Na⁺/I⁻ symporter (NIS) enables Tc-99m pertechnetate uptake — this finding is seen only in oncocytoma and Warthin tumor. Dense mitochondrial content also results in high metabolic activity and FDG uptake. The compact arrangement of oncocytic cells (absence of lymphoid stroma — unlike Warthin) creates a solid, homogeneous mass. Produces intermediate T2 signal — unlike the myxoid matrix of pleomorphic adenoma, the dense cellularity of oncocytic cells shortens T2 time. Absence of cystic component is the most important distinguishing feature from Warthin tumor.
The most distinguishing finding combination of oncocytoma: Tc-99m pertechnetate hot nodule (NIS-mediated uptake) + solid homogeneous structure (no cystic component). Pertechnetate positivity is shared only with Warthin tumor; absence of cystic component distinguishes oncocytoma from Warthin.
On Tc-99m pertechnetate scintigraphy, oncocytoma demonstrates prominent radiotracer uptake (hot nodule). This finding results from oncocytic cells actively accumulating pertechnetate through NIS expression. Among salivary gland tumors, only oncocytoma and Warthin tumor show pertechnetate uptake — this finding has high specificity for distinguishing from all other salivary gland tumors. Differentiation of oncocytoma from Warthin is done with MRI: oncocytoma is solid and homogeneous, Warthin is cystic-solid mixed.
Report Sentence
On Tc-99m pertechnetate scintigraphy, the solid mass in the parotid gland demonstrates prominent uptake (hot nodule); consistent with Warthin tumor or oncocytoma and MRI differentiation is recommended.
On T2-weighted sequences, oncocytoma appears as a solid, homogeneous mass showing intermediate signal. This T2 signal level differs from the marked hyperintensity of pleomorphic adenoma. No cystic component — the most important distinguishing finding from Warthin tumor. Capsule may be seen as thin hypointense rim on T2.
Report Sentence
A well-defined, solid homogeneous mass showing intermediate signal on T2-weighted sequences is identified in the parotid gland; absence of cystic component distinguishes oncocytoma from Warthin tumor and diagnosis is supported by pertechnetate uptake.
On post-contrast T1 sequences, oncocytoma shows homogeneous and prominent enhancement. The high metabolic activity and good vascularization of oncocytic cells explains the enhancement. Isointense signal to muscle on native T1.
Report Sentence
The lesion demonstrates homogeneous and prominent enhancement on post-contrast series; consistent with a well-vascularized solid tumor.
On CT, oncocytoma appears as a well-defined, homogeneously enhancing solid mass. Soft tissue density on non-contrast CT. No cystic component, necrosis, or calcification. CT findings are not specific and may not be distinguishable from other solid parotid tumors — scintigraphy and MRI are needed for diagnosis.
Report Sentence
A well-defined, homogeneously enhancing solid mass is identified in the parotid gland; scintigraphy and MRI are recommended for specific diagnosis.
On B-mode US, oncocytoma appears as a well-defined, homogeneous hypoechoic solid mass. No cystic component — distinguishing from Warthin tumor. Internal vascularity is present on Doppler. Echogenic capsule may be observed. Posterior acoustic enhancement is generally not prominent.
Report Sentence
A well-defined, homogeneous hypoechoic solid mass is identified in the parotid gland; no cystic component and further evaluation with scintigraphy is recommended.
Criteria
Tumor entirely composed of oncocytic cells, solid homogeneous.
Distinct Features
Well-defined, encapsulated, pertechnetate hot, homogeneous enhancement, no cystic component.
Criteria
Multiple small oncocytic nodules. Very rare.
Distinct Features
Bilateral parotid involvement possible, multiple small nodules, in the setting of diffuse oncocytic metaplasia.
Criteria
Malignant transformation of oncocytic cells. Very rare.
Distinct Features
Irregular margins, invasion, necrosis, low ADC, lymph node metastasis. Pertechnetate uptake may be preserved or lost.
Distinguishing Feature
Warthin is cystic-solid mixed (oncocytoma is solid), T1 hyperintense cystic component (absent in oncocytoma), parotid tail (oncocytoma anywhere), bilateral/multifocal (rare in oncocytoma).
Distinguishing Feature
Pleomorphic adenoma is pertechnetate negative (cold nodule), T2 markedly hyperintense (oncocytoma intermediate), high ADC. Oncocytoma is pertechnetate positive (hot), T2 intermediate, ADC intermediate-to-low.
Distinguishing Feature
Acinic cell carcinoma is pertechnetate negative, low ADC (malignant), T2 intermediate (similar). Oncocytoma is pertechnetate positive, intermediate ADC (benign).
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
İİAB ile tanı doğrulama önerilir. Cerrahi: süperfisiyal parotidektomi. Asemptomatik küçük lezyonlarda izlem kabul edilebilir. Malign dönüşüm çok nadir. Rekürrens oranı düşük.Oncocytoma is a benign tumor and the treatment approach is conservative. Diagnosis can be confirmed with FNAB but definitive differentiation from Warthin tumor is histological. Surgical indication is size increase, cosmetic concerns, or suspicion of malignancy. Superficial parotidectomy is the standard surgical approach; facial nerve must be preserved. Recurrence is rare (below 5%). Malignant transformation (oncocytic carcinoma) is very rare but long-term follow-up is recommended. The combination of pertechnetate scintigraphy and MRI provides high diagnostic accuracy.
Surgical excision is the treatment option. Malignant transformation is very rare.